Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.35 - $2.12 $18,419 - $28,925
13,644 New
13,644 $19,000
Q3 2021

Nov 15, 2021

SELL
$6.6 - $12.78 $231,000 - $447,300
-35,000 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$12.14 - $20.35 $118,510 - $198,656
-9,762 Reduced 21.81%
35,000 $462,000
Q1 2021

May 17, 2021

SELL
$16.87 - $31.21 $630,178 - $1.17 Million
-37,355 Reduced 45.49%
44,762 $909,000
Q4 2020

Feb 16, 2021

BUY
$10.89 - $20.16 $894,254 - $1.66 Million
82,117 New
82,117 $1.66 Million

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $55.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.